NCT04479982

Brief Summary

To detect microbial infection and AMR associated with COVID 19 infection. To correlate risk factors of COVID 19 patients with microbial infections and their effects on disease.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 17, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 21, 2020

Completed
2 months until next milestone

Study Start

First participant enrolled

September 24, 2020

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2020

Completed
Last Updated

September 22, 2020

Status Verified

September 1, 2020

Enrollment Period

3 months

First QC Date

July 17, 2020

Last Update Submit

September 20, 2020

Conditions

Covid19

Outcome Measures

Primary Outcomes (1)

  • Microbial infections and antimicrobial resistance (AMR) patterns associated with hospitalized patients with 2019 novel coronavirus disease (COVID 19)

    The correlation between microbial infection and COVID 19 infection and their effect on prognosis and disease outcome.

    baseline

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Hospitalized patients with covid 19

You may qualify if:

  • Patients with Covid infection

You may not qualify if:

  • Patients without covid 19

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assiut hopital

Asyut, 6001, Egypt

RECRUITING

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Central Study Contacts

Alshymaa Ali, PHD

CONTACT

01090581638shimaafahim25@gmail.com

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assistant lecturer

Study Record Dates

First Submitted

July 17, 2020

First Posted

July 21, 2020

Study Start

September 24, 2020

Primary Completion

December 31, 2020

Study Completion

December 31, 2020

Last Updated

September 22, 2020

Record last verified: 2020-09

Locations

EG(1)